De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca

NCT01530997 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Squamous Cell
Head and Neck Neoplasms
Oropharyngeal Neoplasms

Interventions

RADIATION: Intensity Modulated Radiotherapy (IMRT)
DRUG: Cisplatin
PROCEDURE: Limited surgical evaluation

Sponsor

UNC Lineberger Comprehensive Cancer Center